Should daptomycin-rifampin combinations for MSSA/MRSA isolates be avoided because of antagonism?
about
New Insight into Daptomycin Bioavailability and Localization in Staphylococcus aureus Biofilms by Dynamic Fluorescence Imaging[Antibiotic stewardship and Staphylococcus aureus Bacteremia].Combination Susceptibility Testing of Common Antimicrobials in Vitro and the Effects of Sub-MIC of Antimicrobials on Staphylococcus aureus Biofilm Formation.Antimicrobial Effects of Sulfonyl Derivative of 2(5H)-Furanone against Planktonic and Biofilm Associated Methicillin-Resistant and -Susceptible Staphylococcus aureus.
P2860
Should daptomycin-rifampin combinations for MSSA/MRSA isolates be avoided because of antagonism?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Should daptomycin-rifampin com ...... avoided because of antagonism?
@en
Should daptomycin-rifampin com ...... avoided because of antagonism?
@nl
type
label
Should daptomycin-rifampin com ...... avoided because of antagonism?
@en
Should daptomycin-rifampin com ...... avoided because of antagonism?
@nl
prefLabel
Should daptomycin-rifampin com ...... avoided because of antagonism?
@en
Should daptomycin-rifampin com ...... avoided because of antagonism?
@nl
P2093
P2860
P1433
P1476
Should daptomycin-rifampin com ...... avoided because of antagonism?
@en
P2093
P2860
P2888
P304
P356
10.1007/S15010-016-0874-2
P577
2016-01-21T00:00:00Z